Latest news with #accreditedinvestors
Globe and Mail
09-06-2025
- Business
- Globe and Mail
MedX Announces Final Closing of Non-Brokered Private Placement
MedX Health Corp. (' MedX ' or the ' Company ') (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closing and further Closing, it has completed a final Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Final Closing comprised the issuance of 8,678,571 Units (as described below) and raised cash proceeds of $607,500, bringing the total amount raised in the Placement to $2,063,500. Securities issued are subject to a regulatory 'hold' period of four months and one day from the date of issuance. Under this Non-Brokered Private Placement, the Company issued a total of 29,478,571 Units at $0.07 per Unit ('Unit'). Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant (' Warrant ( s)'), exercisable to purchase One (1) further Common Share at the price of $0.09, during the period of one year commencing on the date of issuance. Three Insiders participated in this Placement to the extent of $500,000, for the acquisition of a total of 7,142,857 Units. In connection with the issuance of Units to those Insiders, the Company relies on exemptions from formal valuation and minority shareholder approval requirements set out in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (' MI 61-101 '). as (i) the fair market value of the proposed placement to the Insiders does not exceed 25% of the market capitalization of the Company and (ii) the conditions in section 5.7(1)(a), section 5.7(1)(b) and section 5.7(1)(e) of MI 61-101 are met. Qualified agents received total cash commissions of $15,880, (equal to 8% of the gross proceeds received by the Company from the sale of the Units to subscribers introduced by such agent(s)), and 226,857 agent's warrants (' Agent's Warrant(s) ') (equal to 8% of subscriptions introduced by such agent(s)). Each Agent's Warrant, which is non-transferable, entitles the holder to acquire, at the price of CAD$0.07, a unit, comprised of One (1) fully paid Common Share and one (1) non-transferable share purchase warrant (' Agent's Share Purchase Warrant '), entitling the holder to acquire one additional Common Share at the price of CAD$0.09. The Agent's Warrants and any Agent's Share Purchase Warrants that may be issued pursuant to exercise of an Agent's Warrant, if not exercised, will expire one year following the date of issuance. Funds raised in this Placement are being be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes. About MedX Health Corp.: MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union and Turkey. Visit This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties.
Bloomberg
06-06-2025
- Business
- Bloomberg
Private Equity in 401(k)s Isn't as Smart as It Seems
Should regular Americans be allowed to put more of their retirement savings into private investments long reserved for the wealthy? The White House is seriously considering the proposal, at the behest of some of the country's largest financial firms. This has never been a good idea. The pitch sounds compelling. Accredited investors — professionals and relatively well-off individuals — have entrusted trillions of dollars to private capital funds, which purport to generate superior returns by locking up money for multiyear periods in assets ranging from infrastructure to business loans. American workers with more than $12 trillion in retirement accounts such as 401(k)s have long time horizons, too. Why not let them share in the riches instead of confining them to publicly traded securities?
Crypto Insight
30-05-2025
- Business
- Crypto Insight
Russia allows banks to offer crypto products to accredited investors
The Bank of Russia has permitted financial institutions to offer certain cryptocurrency-based financial instruments to accredited investors. Russian banks are now free to provide qualified investors with a range of crypto products, including crypto derivatives, securities and other digital financial assets tied to crypto prices, the central bank announced on May 28. A key stipulation, however, is that these products must not involve the 'actual delivery of cryptocurrencies,' the Bank of Russia emphasized. The announcement came alongside the Bank of Russia reporting a 51% increase in crypto asset inflows by Russian residents in the first quarter of 2025, totaling 7.3 trillion rubles ($81.5 billion). T-Bank among the first to offer Bitcoin investment products Some major Russian banks started rolling out cryptocurrency investment products immediately following the Bank of Russia's announcement. T-Bank (formerly Tinkoff Bank), one of the largest commercial banks in Russia, announced on May 29 the offering of digital financial assets (DFA) tied to Bitcoin . 'The tool allows you to invest in cryptocurrency in rubles through a familiar application — safely and within the legal framework of the Russian Federation, without opening an account on a crypto exchange and difficulties with protecting your wallet,' the bank said. T-Bank's new 'smart asset' offering is issued through the Russian state-backed tokenization platform Atomyze and is available exclusively to accredited investors. Direct crypto investments still not encouraged While greenlighting local lenders to offer crypto products, the Russian central bank still maintains a restrictive approach regarding direct cryptocurrency investment. 'The Bank of Russia still does not recommend financial institutions and their clients to invest directly in cryptocurrencies,' the Bank of Russia said in a statement. The central bank also noted the ongoing government discussions on the potential launch of an experimental regime that would allow certain investors to trade crypto assets like Bitcoin directly. Russia's estimated CEX holdings are at $9.2 billion In its latest financial stability review, the Bank of Russia estimated Russians' crypto holdings on centralized exchanges (CEXs) at 827 billion rubles ($9.2 billion). According to the authority, Bitcoin is leading Russians' CEX holdings with a 62% share, with Ether following at 22%. Stablecoins like Tether USDt and Circle's USDC ranked third with a share of 15.9%. Some local crypto enthusiasts observed that the actual figure of cryptocurrency held by Russians is significantly bigger than the estimated CEX holdings reported by the Bank of Russia. 'I know that [Pavel] Durov and [Alexey] Bilyuchenko alone have more money in their wallets than this amount,' Sergey Mendeleev, founder of the digital settlement exchange Exved, wrote on his Telegram channel. He hinted that Russians hold much bigger crypto amounts in wallets and decentralized exchanges. Source:
Associated Press
27-05-2025
- Business
- Associated Press
Kumo Capital Expands Real Estate Investment Footprint Beyond Massachusetts
05/27/2025, Boston, Massachusetts // PRODIGY: Feature Story // Kumo Capital, a data-driven real estate investment firm based in Massachusetts, announced the expansion of its operations into new markets, including Michigan, Ohio, Texas, and the Carolinas. It's a significant pivot for the company as it widens its scope to include industrial assets, specifically the small- and shallow-bay segment, applying the same principles that have delivered consistent value for its investors in multifamily real estate. 'What we've done successfully in multifamily housing, like finding value in underutilized assets, improving them, and delivering attractive returns, is exactly what we're now applying in the industrial sector,' says Boris Kuritnik, President of Kumo Capital. 'The small bay space is what we call the 'multifamily of industrial.' It's fragmented, under-managed, but full of potential. Our team has the experience, tools, and rigor to unlock that value.' Since its establishment, Kumo Capital has been committed to transparency and long-term value creation. It has earned a reputation for offering accredited investors access to a portfolio of real estate assets that balance income generation and strategic growth. Specializing in multifamily, commercial, and industrial investments, the firm tailored its approach to emphasize consistent returns and low downside risk. It combines old-school fundamentals and modern data analytics by leveraging extensive experience across asset management, syndication, institutional capital, and underwriting. Kumo Capital operates under a value-add philosophy. It targets properties with untapped growth potential, which are usually acquired below replacement cost in markets with barriers to entry. These assets are typically owned by long-term holders who haven't fully realized their value due to low debt service or passive management. Kumo Capital's strategy extends to income-driven investments in 'core-plus' locations. These are properties that provide immediate cash flow through stable tenancy. The firm also selectively engages in entitlements and ground-up construction. It bridges the gap between existing conditions and market potential through physical improvements, strategic leasing efforts, and operational optimization. This can mean enhancing curb appeal and signage uniformity in industrial parks or upgrading kitchens and bathrooms in multifamily units. Ultimately, the goal is to boost net operating income and asset valuation. The company's expansion to small bay industrial properties beyond Massachusetts is a logical next step, given its track record of providing diversified income streams. Small bay properties serve multiple essential businesses, including contractors, tradespeople, and light manufacturers, who remain relatively insulated from consumer market volatility. Kumo Capital can reduce vacancy and create stability through tenant diversification by targeting spaces in the 5,000 to 20,000 square foot range. Kuritnik's broader market outlook supports this move. He states that high-profile industrial assets like e-commerce mega-warehouses attract headlines. However, they also attract competition and risk. On the other hand, as Kumo Capital has observed, smaller, functionally versatile properties have seen steady demand even through economic fluctuations. 'Small bay will carry the day. These are the buildings that keep America working. It's these low-maintenance, easy-to-re-lease assets that are crucial to local economies. Why? Because they're resilient. And that's what we need given the changes in the sector,' Michael Kuritnik, Chief Operating Officer, states. Kumo Capital has entered its next chapter with its expansion. As the firm continues to focus on systematically improving lower-risk, cash-flowing properties beyond Massachusetts, it welcomes new capital partners to join in this growth. Media Contact Name: Boris Kuritnik Email: [email protected] Source published by Submit Press Release >> Kumo Capital Expands Real Estate Investment Footprint Beyond Massachusetts
National Post
22-05-2025
- Business
- National Post
MedX Announces Further Closing of Non-Brokered Private Placement
Article content MISSISSAUGA, Ontario — MedX Health Corp. (' MedX ' or the ' Company ') (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, announcing an Initial Closing, it has completed a further Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Further Closing comprised the issuance of 7,300,000 Units (as described below) and raised cash proceeds of $511,000, bringing the total amount raised so far to $1,456,000. Securities issued are subject to a regulatory 'hold' period of four months and one day from the date of issuance. Further Closing(s) of the Placement will be subject to receipt of further subscriptions and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. Under this Non-Brokered Private Placement, the Company intends issue of up to a maximum of 35,714,858 Units at $0.07 per Unit ('Unit') to raise a Maximum amount of $2,500,000. Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant (' Warrant (s)'), exercisable to purchase One (1) further Common Share at the price of $0.09, during the period of one year commencing on the date of issuance. It is anticipated that, subject to compliance with relevant regulatory provisions, certain Insiders may participate in this Placement at a subsequent Closing, though to not more than 25% of the total funds raised. Qualified agents will receive a cash commission equal to 8% of the gross proceeds received by the Company from the sale of the Units to subscribers introduced by such agent(s) and agent's warrants (' Agent's Warrant(s) ') equal to 8% of subscriptions introduced by such agent(s). Each Agent's Warrant, which will be non-transferable, will entitle the holder to acquire, at the price of CAD$0.07, a unit, comprised of One (1) fully paid Common Share and one (1) non-transferable share purchase warrant (' Agent's Share Purchase Warrant '), entitling the holder to acquire one additional Common Share at the price of CAD$0.09. The Agent's Warrants and any Agent's Share Purchase Warrants that may be issued pursuant to exercise of an Agent's Warrant, if not exercised, will expire one year following the date of issuance. Article content Article content Funds raised in this Placement will be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes. Article content About MedX Health Corp.: Article content MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union and Turkey. Visit Article content Article content Article content Article content Contacts Article content Article content Article content
